sk&f 86466 has been researched along with calpain inhibitor iii in 1 studies
| Studies (sk&f 86466) | Trials (sk&f 86466) | Recent Studies (post-2010) (sk&f 86466) | Studies (calpain inhibitor iii) | Trials (calpain inhibitor iii) | Recent Studies (post-2010) (calpain inhibitor iii) |
|---|---|---|---|---|---|
| 73 | 3 | 9 | 187 | 0 | 76 |
| Protein | Taxonomy | sk&f 86466 (IC50) | calpain inhibitor iii (IC50) |
|---|---|---|---|
| Calpain-9 | Homo sapiens (human) | 1.61 | |
| Calpain-1 catalytic subunit | Homo sapiens (human) | 0.183 | |
| Procathepsin L | Homo sapiens (human) | 0.6365 | |
| Cathepsin B | Homo sapiens (human) | 0.5186 | |
| Calpain-2 catalytic subunit | Homo sapiens (human) | 0.35 | |
| Calpain-1 catalytic subunit | Sus scrofa (pig) | 0.02 | |
| Vascular endothelial growth factor receptor 2 | Homo sapiens (human) | 0.1 | |
| Falcipain 2B | Plasmodium falciparum (malaria parasite P. falciparum) | 5 | |
| Cysteine proteinase falcipain 2a | Plasmodium falciparum (malaria parasite P. falciparum) | 5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
1 other study(ies) available for sk&f 86466 and calpain inhibitor iii
| Article | Year |
|---|---|
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |